Matthew M Walsh - Net Worth and Insider Trading
Matthew M Walsh Net Worth
The estimated net worth of Matthew M Walsh is at least $13 Million dollars as of 2025-04-30. Matthew M Walsh is the See Remarks of Catalent Inc and owns about 88,188 shares of Catalent Inc (CTLT) stock worth over $6 Million. Matthew M Walsh is the EVP, CFO of Allergan PLC and owns about 26,416 shares of Allergan PLC (AGN) stock worth over $5 Million. Matthew M Walsh is also the Director of Certara Inc and owns about 167,901 shares of Certara Inc (CERT) stock worth over $2 Million. Details can be seen in Matthew M Walsh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew M Walsh has not made any transactions after 2022-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew M Walsh
Matthew M Walsh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew M Walsh owns 5 companies in total, including Catalent Inc (CTLT) , Multi-Color Corp (LABL) , and Spectrum Group International Inc (SPGZ) among others .
Click here to see the complete history of Matthew M Walsh’s form 4 insider trades.
Insider Ownership Summary of Matthew M Walsh
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| CTLT | Catalent Inc | 2016-05-27 | See Remarks |
| LABL | Multi-Color Corp | 2016-10-03 | director |
| SPGZ | Spectrum Group International Inc | 2006-05-11 | CFO AND EXE. V.P. |
 | | 2021-05-07 | Chief Financial Officer |
| | 2022-11-14 | director |
Matthew M Walsh Latest Holdings Summary
Matthew M Walsh currently owns a total of 3 stocks. Among these stocks, Matthew M Walsh owns 88,188 shares of Catalent Inc (CTLT) as of May 27, 2016, with a value of $6 Million and a weighting of 42.98%. Matthew M Walsh owns 26,416 shares of Allergan PLC (AGN) as of November 16, 2018, with a value of $5 Million and a weighting of 39.15%. Matthew M Walsh also owns 167,901 shares of Certara Inc (CERT) as of November 14, 2022, with a value of $2 Million and a weighting of 17.87%.
Latest Holdings of Matthew M Walsh
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTLT | Catalent Inc | 2016-05-27 | 88,188 | 63.48 | 5,598,174 |
| AGN | Allergan PLC | 2018-11-16 | 26,416 | 193.02 | 5,098,816 |
| CERT | Certara Inc | 2022-11-14 | 167,901 | 13.86 | 2,327,108 |
Holding Weightings of Matthew M Walsh
Matthew M Walsh Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew M Walsh has made a total of 0 transactions in Catalent Inc (CTLT) over the past 5 years. The most-recent trade in Catalent Inc is the sale of 21,197 shares on May 27, 2016, which brought Matthew M Walsh around $611,533.
According to the SEC Form 4 filings, Matthew M Walsh has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the acquisition of 1,000 shares on November 16, 2018, which cost Matthew M Walsh around $157,000.
According to the SEC Form 4 filings, Matthew M Walsh has made a total of 2 transactions in Certara Inc (CERT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Certara Inc is the sale of 12,059 shares on November 14, 2022, which brought Matthew M Walsh around $177,750.
Insider Trading History of Matthew M Walsh
- 1
Matthew M Walsh Trading Performance
GuruFocus tracks the stock performance after each of Matthew M Walsh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew M Walsh is -4.25%. GuruFocus also compares Matthew M Walsh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew M Walsh within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew M Walsh's insider trading performs compared to the benchmark.
Performance of Matthew M Walsh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.49 | | | | | |
| Relative Return to S&P 500(%) | 3.37 | | | | | |
Matthew M Walsh Ownership Network
Ownership Network List of Matthew M Walsh
Ownership Network Relation of Matthew M Walsh
Matthew M Walsh Owned Company Details
What does Catalent Inc do?
Who are the key executives at Catalent Inc?
Matthew M Walsh is the See Remarks of Catalent Inc. Other key executives at Catalent Inc include SVP & General Counsel & CCO Joseph Anthony Ferraro , Group President & Biologics David Mcerlane , and See Remarks Aristippos Gennadios .
Catalent Inc (CTLT) Insider Trades Summary
Over the past 18 months, Matthew M Walsh made no insider transaction in Catalent Inc (CTLT). Other recent insider transactions involving Catalent Inc (CTLT) include a net sale of 2,269 shares made by Ricky Hopson , a net sale of 1,336 shares made by Scott Gunther , and a net sale of 1,518 shares made by Aristippos Gennadios .
In summary, during the past 3 months, insiders sold 0 shares of Catalent Inc (CTLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,785 shares of Catalent Inc (CTLT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,785 shares.
Catalent Inc (CTLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalent Inc Insider Transactions
Matthew M Walsh Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew M Walsh. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew M Walsh's mailing address is: Madison Nj 07940.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
